RHOEN KLINIKUMRHOEN KLINIKUMRHOEN KLINIKUM

RHOEN KLINIKUM

No trades
See on Supercharts
Market capitalization
‪767.98 M‬CHF
‪35.97 M‬CHF
‪1.55 B‬CHF
‪4.41 M‬
Beta (1Y)
0.46

About RHOEN KLINIKUM

CEO
Tobias Kaltenbach
Headquarters
Bad Neustadt an der Saale
Employees (FY)
‪18.25 K‬
Founded
1973
ISIN
DE0007042301
FIGI
BBG006TLTLK8
Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RHK is 26.0 CHF — it has decreased by 11.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange RHOEN KLINIKUM stocks are traded under the ticker RHK.
RHOEN KLINIKUM is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RHK stock is 13.46% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is RHOEN KLINIKUM there?
RHOEN KLINIKUM revenue for the last quarter amounts to ‪355.31 M‬ CHF despite the estimated figure of ‪353.53 M‬ CHF. In the next quarter revenue is expected to reach ‪347.05 M‬ CHF.
Yes, you can track RHOEN KLINIKUM financials in yearly and quarterly reports right on TradingView.
RHK net income for the last quarter is ‪14.45 M‬ CHF, while the quarter before that showed ‪10.81 M‬ CHF of net income which accounts for 33.67% change. Track more RHOEN KLINIKUM financial stats to get the full picture.
Today RHOEN KLINIKUM has the market capitalization of ‪850.11 M‬, it has decreased by 9.33% over the last week.
Yes, RHK dividends are paid annually. The last dividend per share was 0.15 CHF. As of today, Dividend Yield (TTM)% is 1.15%. Tracking RHOEN KLINIKUM dividends might help you take more informed decisions.
Like other stocks, RHK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RHOEN KLINIKUM stock right from TradingView charts — choose your broker and connect to your account.
RHK reached its all-time high on Dec 18, 2017 with the price of 35.2 CHF, and its all-time low was 23.0 CHF and was reached on Jan 16, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪18.25 K‬ employees. See our rating of the largest employees — is RHOEN KLINIKUM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RHOEN KLINIKUM technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RHOEN KLINIKUM stock shows the strong sell signal. See more of RHOEN KLINIKUM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RHOEN KLINIKUM EBITDA is ‪46.51 M‬ CHF, and current EBITDA margin is 2.73%. See more stats in RHOEN KLINIKUM financial statements.